TrialCancer chemotherapy and pharmacology2024

Population pharmacokinetic and exposure-toxicity analyses of nab-paclitaxel after pegylated recombinant human granulocyte colony-stimulating factor administration in patients with metastatic breast cancer.

Dihong Yang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.